Hedge Funds Are Buying Albany Molecular Research, Inc. (AMRI): Osiris Therapeutics, Inc. (OSIR), 3SBio Inc. (ADR) (SSRX)

Is Albany Molecular Research, Inc. (NASDAQ:AMRI) the right investment to pursue these days? Investors who are in the know are in an optimistic mood. The number of bullish hedge fund bets improved by 2 recently.

Chuck Royce

If you’d ask most shareholders, hedge funds are perceived as underperforming, outdated investment tools of the past. While there are more than 8000 funds with their doors open today, we at Insider Monkey look at the leaders of this group, around 450 funds. It is estimated that this group oversees the lion’s share of all hedge funds’ total capital, and by paying attention to their top investments, we have figured out a few investment strategies that have historically outperformed Mr. Market. Our small-cap hedge fund strategy outperformed the S&P 500 index by 18 percentage points annually for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have outpaced the S&P 500 index by 24 percentage points in 7 months (see the details here).

Just as key, optimistic insider trading sentiment is another way to break down the world of equities. Obviously, there are many incentives for a bullish insider to sell shares of his or her company, but just one, very simple reason why they would behave bullishly. Many empirical studies have demonstrated the impressive potential of this method if investors understand where to look (learn more here).

Now, we’re going to take a look at the key action regarding Albany Molecular Research, Inc. (NASDAQ:AMRI).

Hedge fund activity in Albany Molecular Research, Inc. (NASDAQ:AMRI)

At the end of the fourth quarter, a total of 10 of the hedge funds we track were long in this stock, a change of 25% from one quarter earlier. With hedgies’ sentiment swirling, there exists a select group of key hedge fund managers who were upping their stakes considerably.

Of the funds we track, Royce & Associates, managed by Chuck Royce, holds the largest position in Albany Molecular Research, Inc. (NASDAQ:AMRI). Royce & Associates has a $8 million position in the stock, comprising 0% of its 13F portfolio. On Royce & Associates’s heels is Visium Asset Management, managed by Jacob Gottlieb, which held a $5 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Some other peers with similar optimism include John W. Rogers’s Ariel Investments, Jim Simons’s Renaissance Technologies and D. E. Shaw’s D E Shaw.

Consequently, key money managers have jumped into Albany Molecular Research, Inc. (NASDAQ:AMRI) headfirst. AQR Capital Management, managed by Cliff Asness, established the most valuable position in Albany Molecular Research, Inc. (NASDAQ:AMRI). AQR Capital Management had 0 million invested in the company at the end of the quarter. Peter Algert and Kevin Coldiron’s Algert Coldiron Investors also initiated a $0 million position during the quarter. The only other fund with a brand new AMRI position is Steven Cohen’s SAC Capital Advisors.

What do corporate executives and insiders think about Albany Molecular Research, Inc. (NASDAQ:AMRI)?

Insider trading activity, especially when it’s bullish, is best served when the company in focus has experienced transactions within the past 180 days. Over the last half-year time frame, Albany Molecular Research, Inc. (NASDAQ:AMRI) has seen 2 unique insiders buying, and 2 insider sales (see the details of insider trades here).

Let’s also examine hedge fund and insider activity in other stocks similar to Albany Molecular Research, Inc. (NASDAQ:AMRI). These stocks are Osiris Therapeutics, Inc. (NASDAQ:OSIR), 3SBio Inc. (ADR) (NASDAQ:SSRX), PROLOR Biotech Inc (NYSEAMEX:PBTH), XenoPort, Inc. (NASDAQ:XNPT), and Novavax, Inc. (NASDAQ:NVAX). This group of stocks are the members of the biotechnology industry and their market caps are similar to AMRI’s market cap.

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Osiris Therapeutics, Inc. (NASDAQ:OSIR) 1 1 3
3SBio Inc. (ADR) (NASDAQ:SSRX) 9 0 0
PROLOR Biotech Inc (NYSEAMEX:PBTH) 3 0 0
XenoPort, Inc. (NASDAQ:XNPT) 13 0 0
Novavax, Inc. (NASDAQ:NVAX) 5 1 0

With the results demonstrated by our strategies, everyday investors must always watch hedge fund and insider trading activity, and Albany Molecular Research, Inc. (NASDAQ:AMRI) is no exception.

Click here to learn why you should track hedge funds

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!